Health and Healthcare Systems

Spaceflight reactivates dormant viruses. This could be a problem if we want to go to Mars

NASA picture inside the Cupola aboard the International Space Station shows NASA astronaut Chris Cassidy, an Expedition 36 flight engineer, using a 400mm lens on a digital still camera to photograph a target of opportunity on Earth some 250 miles below him in this NASA image released on June 10, 2013. Cassidy has been aboard the orbital outpost since late March and will continue his stay into September.  REUTERS/NASA/Handout via Reuters  (OUTER SPACE - Tags: SCIENCE TECHNOLOGY TPX IMAGES OF THE DAY)  ATTENTION EDITORS - THIS IMAGE WAS PROVIDED BY A THIRD PARTY. FOR EDITORIAL USE ONLY. NOT FOR SALE FOR MARKETING OR ADVERTISING CAMPAIGNS. THIS PICTURE WAS PROCESSED BY REUTERS TO ENHANCE QUALITY. AN UNPROCESSED VERSION WILL BE PROVIDED SEPARATELY - GM1E96A1TX601

The new evidence of viral reactivation could have important implications for long-distance space travel. Image: REUTERS/NASA/Handout via Reuters

Matthew Prior
Writer, Frontiers Science News

Herpes viruses reactivate in more than half of crew aboard Space Shuttle and International Space Station missions, according to NASA research published in Frontiers in Microbiology. While only a small proportion develop symptoms, virus reactivation rates increase with spaceflight duration and could present a significant health risk on missions to Mars and beyond.

NASA’s rapid viral detection systems and ongoing treatment research are beginning to safeguard astronauts – and immunocompromised patients on Earth, too.

Herpes viruses reactivate in immunocompromised astronauts

“NASA astronauts endure weeks or even months exposed to microgravity and cosmic radiation – not to mention the extreme G forces of take-off and re-entry,” says senior author Dr. Satish K. Mehta of KBR Wyle at the Johnson Space Center. “This physical challenge is compounded by more familiar stressors like social separation, confinement and an altered sleep-wake cycle.”

Image: Frontiers in Microbiology

To study the physiological impact of spaceflight, Mehta and colleagues analyze saliva, blood and urine samples collected from astronauts before, during and after spaceflight.

“During spaceflight there is a rise in secretion of stress hormones like cortisol and adrenaline, which are known to suppress the immune system. In keeping with this, we find that astronaut’s immune cells – particularly those that normally suppress and eliminate viruses – become less effective during spaceflight and sometimes for up to 60 days after.”

In the midst of this stress-induced amnesty on viral killing, old enemies reactivate and resurface.

“To date, 47 out of 89 (53%) astronauts on short space shuttle flights, and 14 out of 23 (61%) on longer ISS missions shed herpes viruses in their saliva or urine samples,” reports Mehta. “These frequencies – as well as the quantity – of viral shedding are markedly higher than in samples from before or after flight, or from matched healthy controls.”

Overall, four of the eight known human herpes viruses were detected. These include the varieties responsible for oral and genital herpes (HSV), chickenpox and shingles (VZV) – which remain lifelong in our nerve cells – as well as CMV and EBV, which take permanent but uneventful residence in our immune cells during childhood. CMV and EBV occasionally cause mononucleosis, the “kissing disease”.

Deep-space exploration could depend on effective prevention and treatment

So far, this viral shedding is typically asymptomatic.

“Only six astronauts developed any symptoms due to viral reactivation,” says Mehta. “All were minor skin lesions.”

However, continued virus shedding post flight could endanger immunocompromised or uninfected contacts on Earth, particularly newborns.

“Infectious VZV and CMV were shed in body fluids up to 30 days following return from the International Space Station.”

What’s more, as we prepare for human deep-space missions beyond the moon and Mars, the risk that herpes virus reactivation poses to astronauts and their contacts could become more crucial.

Have you read?

“The magnitude, frequency and duration of viral shedding all increase with length of spaceflight.”

Coupled with that fact that more than one virus generally reactivates at a time, the physiological ramifications of herpes reactivation during prolonged spaceflight could run to permanent vision and hearing loss and even organ failure.

Developing countermeasures to viral reactivation is essential to the success of these deep-space missions, argues Mehta.

“The ideal countermeasure is vaccination for astronauts – but this is so far available only against VZV.”

“Trials of other herpes virus vaccines show little promise, so our present focus is on developing targeted treatment regimens for individuals suffering the consequences of viral reactivation.

“This research has tremendous clinical relevance for patients on Earth too. Already, our spaceflight-developed technologies for rapid viral detection in saliva have been employed in clinics and hospitals around the world.”

Don't miss any update on this topic

Create a free account and access your personalized content collection with our latest publications and analyses.

Sign up for free

License and Republishing

World Economic Forum articles may be republished in accordance with the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Public License, and in accordance with our Terms of Use.

The views expressed in this article are those of the author alone and not the World Economic Forum.

Stay up to date:

Space

Share:
The Big Picture
Explore and monitor how Space is affecting economies, industries and global issues
A hand holding a looking glass by a lake
Crowdsource Innovation
Get involved with our crowdsourced digital platform to deliver impact at scale
World Economic Forum logo
Global Agenda

The Agenda Weekly

A weekly update of the most important issues driving the global agenda

Subscribe today

You can unsubscribe at any time using the link in our emails. For more details, review our privacy policy.

COPD kills more than lung and breast cancer combined. It's time to change that

Nitin Kapoor

November 22, 2024

A historic leap in cancer vaccines – here’s what you need to know

About us

Engage with us

  • Sign in
  • Partner with us
  • Become a member
  • Sign up for our press releases
  • Subscribe to our newsletters
  • Contact us

Quick links

Language editions

Privacy Policy & Terms of Service

Sitemap

© 2024 World Economic Forum